Sage Journals: Discover world-class research

Retricted access

Review article

First published 2019-10

Rationale for the evaluation of nintedanib as a treatment for systemic sclerosis–associated interstitial lung disease

Lutz Wollin, Jörg HW Distler, Christopher P Denton [...]

Journal of Scleroderma and Related Disorders

Open access

Research article

First published 2020-3

Pathogenesis of systemic sclerosis associated interstitial lung disease

Svetlana I Nihtyanova, Christopher P Denton

Journal of Scleroderma and Related Disorders

Open access

Research article

First published 2020

Patient and Physician Perspectives on Systemic Sclerosis–Associated Interstitial Lung Disease

Tariq J Cheema, Meilin Young, Erica Rabold [...]

Therapeutic Advances in Pulmonary and Critical Care Medicine

Open access

Review article

First published 2022-10

Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography

Dinesh Khanna, Oliver Distler, Vincent Cottin [...]

Journal of Scleroderma and Related Disorders

Retricted access

Research article

First published 2023-6

COVID-19 and protection of vaccination in patients with systemic sclerosis–associated interstitial lung disease

Stylianos Panopoulos, Vasilios Tzilas, Vasiliki-Kalliopi Bournia [...]

Journal of Scleroderma and Related Disorders

Retricted access

Research article

First published 2020-3

Treatment of systemic sclerosis–associated interstitial lung disease: Lessons from clinical trials

David Roofeh, Oliver Distler, Yannick Allanore [...]

Journal of Scleroderma and Related Disorders

Open access

Review article

First published 2025-10

Physician–patient communication in the treatment of systemic sclerosis–associated interstitial lung disease: A narrative review and recommendations

Masataka Kuwana, Aiko Saito, Sue Farrington [...]

Journal of Scleroderma and Related Disorders

Retricted access

Research article

First published 2023-10

Therapeutic effects of thalidomide on patients with systemic sclerosis-associated interstitial lung disease

Jie Pan, Fei Dong, Li Ma [...]

Journal of Scleroderma and Related Disorders

Retricted access

Research article

First published 2025-10

Patients and physicians differently consider severity and outcomes of systemic sclerosis-associated interstitial lung disease: Results of an international survey

Liubov Petelytska, Muriel Elhai, Ilaria Galetti [...]

Journal of Scleroderma and Related Disorders

Open access

Review article

First published 2022

The role of antifibrotic therapies in the treatment of systemic sclerosis–associated interstitial lung disease

Gonçalo Boleto, Jérôme Avouac, Yannick Allanore

Therapeutic Advances in Musculoskeletal Disease

Search results